Safety and Effectiveness of Ustekinumab for Crohn’s Disease in Japanese Post-marketing Surveillance in Biologic-Naive and -Experienced Conriemed

BACKGROUND: To present the real-world evidence on the safety and effectiveness of ustekinumab (UST) through 52-week treatment for Crohn’s disease (CD) under an analysis of post-market surveillance data in Japan. METHODS: This prospective, post-marketing surveillance study was conducted in 341 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagano, Katsumasa, Hata, Erina, Asano, Teita, Tsuchiya, Hiroaki, Takagishi, Masayuki, Yamazaki, Hiroshi, Tominaga, Sonoko, Matsumoto, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912369/
https://www.ncbi.nlm.nih.gov/pubmed/36777365
http://dx.doi.org/10.1093/crocol/otad001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912369/
https://www.ncbi.nlm.nih.gov/pubmed/36777365
http://dx.doi.org/10.1093/crocol/otad001

Ejemplares similares